HLS Therapeutics Inc
Research HLS Therapeutics Inc (HLS) on Bullrun: market cap CAD 124.47M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHLS
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Market capCAD 124.47M
- Financial periodFY2025
- RevenueUSD 55.50M
- Revenue growth-69.6%
- Net income-USD 12.43M
- Free cash flowUSD 15.43M
- Gross margin81.8%
Valuation Snapshot
latest market cap is CAD 124.47M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 55.50M | -USD 12.43M | USD 15.43M | 81.8% | 0.03 | USD 11.72M | USD 49.82M | USD 61.67M |
| FY2024 | USD 182.47M | USD 7.69M | -USD 13.63M | 38.5% | 0.02 | USD 74.34M | USD 6.99M | USD 219.11M |
| FY2023 | USD 125.60M | -USD 5.82M | -USD 36.82M | 29.5% | -0.02 | USD 30.89M | USD 2.83M | USD 154.29M |
| FY2021 | USD 25.04M | USD 2.50M | -USD 329.00K | 57.5% | 0.02 | USD 29.26M | n/a | USD 69.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-02 | CAD 124.47M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About HLS Therapeutics Inc
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HLS Therapeutics Inc's market cap?
HLS Therapeutics Inc's market capitalization is CAD 124.47M.
What does HLS Therapeutics Inc do?
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.